Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gernot Zollner

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Gastroenterology|August 9, 2005
Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humansHanns-Ulrich Marschall, Martin Wagner, Gernot Zollner, et al.
Gastroenterology|September 2, 2003
Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated miceMartin Wagner, Peter Fickert, Gernot Zollner, et al.
Nutrients|June 27, 2020
Changes in the Intestinal Microbiome during a Multispecies Probiotic Intervention in Compensated CirrhosisAngela Horvath, Marija Durdevic, Bettina Leber, et al.
BMC Nephrology|December 3, 2015
The chronic kidney disease epidemiology collaboration equation combining creatinine and cystatin C accurately assesses renal function in patients with cirrhosisElisabeth Krones, Peter Fickert, Sabine Zitta, et al.
Gastroenterology|February 14, 2006
24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout micePeter Fickert, Martin Wagner, Hanns-Ulrich Marschall, et al.
Arthritis Research & Therapy|October 26, 2017
Ultrasound verified inflammation and structural damage in patients with hereditary haemochromatosis-related arthropathyChristian Dejaco, Andreas Stadlmayr, Christina Duftner, et al.
Respiratory Medicine|September 17, 2022
Pulmonary vascular disease and exercise hemodynamics in chronic liver diseasePhilipp Douschan, Gabor Kovacs, Teresa Sassmann, et al.
Hepatology (Baltimore, Md.)|September 3, 2014
Growth hormone resistance exacerbates cholestasis-induced murine liver fibrosisPatricia Stiedl, Robert McMahon, Leander Blaas, et al.
Clinical Nutrition (Edinburgh, Scotland)|December 17, 2025
An observational study on the effect of l-ornithine-l-aspartate (LOLA) on the gut microbiome in liver cirrhosis. A single center phase 4 studyDaniel Habich, Angela Horvath, Nicole Feldbacher, et al.
Hepatology (Baltimore, Md.)|February 18, 2010
Disruption of the growth hormone--signal transducer and activator of transcription 5--insulinlike growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasisLeander Blaas, Jan-Wilhelm Kornfeld, Daniel Schramek, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Gastroenterology|August 9, 2005
Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humansHanns-Ulrich Marschall, Martin Wagner, Gernot Zollner, et al.
Gastroenterology|September 2, 2003
Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated miceMartin Wagner, Peter Fickert, Gernot Zollner, et al.
Nutrients|June 27, 2020
Changes in the Intestinal Microbiome during a Multispecies Probiotic Intervention in Compensated CirrhosisAngela Horvath, Marija Durdevic, Bettina Leber, et al.
BMC Nephrology|December 3, 2015
The chronic kidney disease epidemiology collaboration equation combining creatinine and cystatin C accurately assesses renal function in patients with cirrhosisElisabeth Krones, Peter Fickert, Sabine Zitta, et al.
Gastroenterology|February 14, 2006
24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout micePeter Fickert, Martin Wagner, Hanns-Ulrich Marschall, et al.
Arthritis Research & Therapy|October 26, 2017
Ultrasound verified inflammation and structural damage in patients with hereditary haemochromatosis-related arthropathyChristian Dejaco, Andreas Stadlmayr, Christina Duftner, et al.
Respiratory Medicine|September 17, 2022
Pulmonary vascular disease and exercise hemodynamics in chronic liver diseasePhilipp Douschan, Gabor Kovacs, Teresa Sassmann, et al.
Hepatology (Baltimore, Md.)|September 3, 2014
Growth hormone resistance exacerbates cholestasis-induced murine liver fibrosisPatricia Stiedl, Robert McMahon, Leander Blaas, et al.
Clinical Nutrition (Edinburgh, Scotland)|December 17, 2025
An observational study on the effect of l-ornithine-l-aspartate (LOLA) on the gut microbiome in liver cirrhosis. A single center phase 4 studyDaniel Habich, Angela Horvath, Nicole Feldbacher, et al.
Hepatology (Baltimore, Md.)|February 18, 2010
Disruption of the growth hormone--signal transducer and activator of transcription 5--insulinlike growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasisLeander Blaas, Jan-Wilhelm Kornfeld, Daniel Schramek, et al.
Pageof 7